Open AccessSGLT-2 inhibitors – are they to stay?
Author(s) -
Arulmozhi D. Kandasamy
Publication year - 2017
Publication title -
diabesity
Language(s) - English
Resource type - Journals
ISSN - 2369-0569
DOI - 10.15562/diabesity.2016.35
Subject(s) - dapagliflozin , medicine , empagliflozin , metformin , diabetic ketoacidosis , diabetes mellitus , type 2 diabetes , pharmacology , drug class , intensive care medicine , drug , endocrinology